|
 |
 |
|
Details For Selected Brain Tumor Treatment
|
 |
|
|
| Sponsored By |
|
| Please Click On The Above Banner For More Details |
|
|
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme |
 |
 |
 |
 |
Phase: |
 |
Phase 2 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1637 NCT00165477 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
60: Requires occasional assistance but is able to care for most of own needs |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Gliadel not allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
11/09/2005 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme Gliosarcoma |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Radiation |
 |
 |
 |
 |
Contact: |
 |
Patrick Wen MD Dana-Farber Cancer Institute Center for Neuro-Oncology
Boston, MA USA Phone: 617-632-6327 Fax: E-mail: Website: |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|
|